KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,229,663 | -13.8% | 2,437,463 | 0.0% | 0.10% | -11.8% |
| Q2 2023 | $25,788,359 | -13.5% | 2,437,463 | 0.0% | 0.11% | -25.2% |
| Q1 2023 | $29,810,172 | -5.4% | 2,437,463 | -4.0% | 0.15% | -23.4% |
| Q4 2022 | $31,504,088 | -33.7% | 2,538,605 | -27.0% | 0.19% | -36.6% |
| Q3 2022 | $47,484,000 | -20.5% | 3,476,105 | +6.7% | 0.30% | -16.1% |
| Q2 2022 | $59,706,000 | +14.5% | 3,257,296 | +0.4% | 0.36% | +32.7% |
| Q1 2022 | $52,144,000 | +57.8% | 3,242,808 | +37.4% | 0.27% | +58.1% |
| Q4 2021 | $33,052,000 | -35.0% | 2,360,831 | -13.0% | 0.17% | -37.7% |
| Q3 2021 | $50,841,000 | -5.8% | 2,714,424 | +4.9% | 0.28% | -9.5% |
| Q2 2021 | $53,955,000 | -14.8% | 2,587,782 | +15.5% | 0.30% | -23.2% |
| Q1 2021 | $63,363,000 | +19.8% | 2,241,352 | +38.4% | 0.40% | +18.9% |
| Q4 2020 | $52,894,000 | +36.6% | 1,619,546 | +28.1% | 0.33% | +13.2% |
| Q3 2020 | $38,735,000 | +166.1% | 1,264,209 | +41.6% | 0.30% | +130.5% |
| Q2 2020 | $14,555,000 | – | 892,928 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |